A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction
Authors:
- 1 August 1997
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 52 (2) , 71-76
Abstract
Two hundred and thirty‐five survivors of myocardial infarction (MI) were compared to 384 controls with respect to distribution of genotypes and gene frequencies in the A1166C polymorphism at the angiotensin II type 1 receptor (AT1R) locus. No differences in allele frequencies or genotype distribution were observed when all patients were compared with all controls. When comparing CC homozygotes with the combined group of CA heterozygotes and AA homozygotes (CA/AA), a difference in borderline significance between the MI group and controls was observed (p = 0.05). In males alone, this difference was much more pronounced because of the larger proportion of males with the CC genotype in MI cases than in male controls (p = 0.01). No significant differences were observed between female cases and controls. No interaction between the insertion/deletion (I/D) polymorphism at the angiotensin I‐converting enzyme (ACE) locus and the polymorphism at the AT1R locus was detected. When subdividing the subjects into a “low‐risk” and a “high‐risk” group, based on levels of apolipoprotein B (apoB) and body mass index (BMI), and whether or not the person used lipid‐lowering drugs, the frequency of CC homozygotes in male cases of the “low‐risk” group differed significantly compared to the frequency in male controls of the “low‐risk” group (p < 0.001). No differences were observed in females, but the number of “low‐risk” group female cases was low (n = 3). Thus, CC homozygosity appears to be associated with MI in Norwegian males, especially among those with a “low‐risk” phenotype.Keywords
This publication has 16 references indexed in Scilit:
- Association of angiotensinogen gene T235 variant with increased risk of coronary heart diseaseThe Lancet, 1995
- A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1995
- A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian populationAtherosclerosis, 1995
- A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart StudyCirculation, 1995
- Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.Hypertension, 1994
- No effect of insertion/ deletion polymorphism at the ACE locus on normal blood pressure level or variabilityClinical Genetics, 1994
- Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarctionClinical Genetics, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Twin Studies of Coronary Heart Disease and Its Risk FactorsActa geneticae medicae et gemellologiae: twin research, 1984